[{"indications": "Indications\u00a0Gram-negative infections including Pseudomonas aeruginosa, Haemophilus influenzae, and Neisseria\r\nmeningitidis", "name": "AZTREONAM Parenteral", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.2 Cephalosporins, carbapenems, and other beta-lactams", "5.1.2.3 Other beta-lactam antibiotics", "AZTREONAM", "Parenteral"], "cautions": "Cautions\u00a0hypersensitivity to beta-lactam antibiotics; interactions: Appendix 1 (aztreonam)Specific cautions for inhaled treatment\u00a0Other\r\ninhaled drugs should be administered before aztreonam; a bronchodilator\r\nshould be administered before each dose ", "side-effects": "Side-effects\u00a0Specific side-effects for parenteral treatment\u00a0Rarely gastro-intestinal bleeding, antibiotic-associated\r\ncolitis, jaundice, hepatitis, hypotension, chest pain, dyspnoea, seizures,\r\nparaesthesia, confusion, dizziness, asthenia, headache, insomnia,\r\nbreast tenderness, blood disorders (including thrombocytopenia and\r\nneutropenia), myalgia, diplopia, tinnitus, halitosis; also reported\r\nnausea, vomiting, abdominal pain, diarrhoea, mouth ulcers,\r\ntaste disturbances, flushing, bronchospasm, rash (including toxic\r\nepidermal necrolysis and erythema multiforme)Specific side-effects for inhaled treatment\u00a0Wheezing,\r\nbronchospasm, cough; pyrexia; rash; rhinorrhoea, pharyngolaryngeal\r\npain", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3801.htm", "doses": ["By deep intramuscular injection or by intravenous injection over 3\u20135 minutes or by intravenous infusion, 1\u00a0g every 8 hours or 2\u00a0g every 12 hours; 2\u00a0g every 6\u20138 hours for severe infections\r\n(including systemic Pseudomonas aeruginosa and\r\nlung infections in cystic fibrosis); single doses over 1\u00a0g intravenous\r\nroute only", "Urinary-tract infections, 0.5\u20131\u00a0g every 8\u201312 hours", "child over 1 week, by\r\nintravenous injection or infusion, 30\u00a0mg/kg every 6\u20138 hours increased in severe infections for child\r\nof 2 years or older to 50\u00a0mg/kg every 6\u20138 hours; max. 8\u00a0g daily", "Gonorrhoea, cystitis, by intramuscular injection, 1\u00a0g as a single dose", "Chronic pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis, by inhalation\r\nof nebulised solution, adult over 18 years, 75\u00a0mg 3 times daily (at least 4 hours apart) for\r\n28 days; if additional courses required, a minimum of 28 days without\r\naztreonam nebuliser solution recommended between courses", "Name[Azactam\u00ae (Squibb) ] Injection, powder for reconstitution, aztreonam, net price 1-g vial = \u00a39.40; 2-g vial = \u00a318.82"], "pregnancy": "Pregnancy\u00a0no information available; manufacturer of injection\r\nadvises avoid; manufacturer of powder for nebuliser solution advises\r\navoid unless essential"}, {"indications": "Indications\u00a0Gram-negative infections including Pseudomonas aeruginosa, Haemophilus influenzae, and Neisseria\r\nmeningitidis", "name": "AZTREONAM Inhalation", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.2 Cephalosporins, carbapenems, and other beta-lactams", "5.1.2.3 Other beta-lactam antibiotics", "AZTREONAM", "Inhalation"], "cautions": "Cautions\u00a0hypersensitivity to beta-lactam antibiotics; interactions: Appendix 1 (aztreonam)Specific cautions for inhaled treatment\u00a0Other\r\ninhaled drugs should be administered before aztreonam; a bronchodilator\r\nshould be administered before each dose ", "side-effects": "Side-effects\u00a0Specific side-effects for parenteral treatment\u00a0Rarely gastro-intestinal bleeding, antibiotic-associated\r\ncolitis, jaundice, hepatitis, hypotension, chest pain, dyspnoea, seizures,\r\nparaesthesia, confusion, dizziness, asthenia, headache, insomnia,\r\nbreast tenderness, blood disorders (including thrombocytopenia and\r\nneutropenia), myalgia, diplopia, tinnitus, halitosis; also reported\r\nnausea, vomiting, abdominal pain, diarrhoea, mouth ulcers,\r\ntaste disturbances, flushing, bronchospasm, rash (including toxic\r\nepidermal necrolysis and erythema multiforme)Specific side-effects for inhaled treatment\u00a0Wheezing,\r\nbronchospasm, cough; pyrexia; rash; rhinorrhoea, pharyngolaryngeal\r\npain", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/209176.htm", "doses": ["By deep intramuscular injection or by intravenous injection over 3\u20135 minutes or by intravenous infusion, 1\u00a0g every 8 hours or 2\u00a0g every 12 hours; 2\u00a0g every 6\u20138 hours for severe infections\r\n(including systemic Pseudomonas aeruginosa and\r\nlung infections in cystic fibrosis); single doses over 1\u00a0g intravenous\r\nroute only", "Urinary-tract infections, 0.5\u20131\u00a0g every 8\u201312 hours", "child over 1 week, by\r\nintravenous injection or infusion, 30\u00a0mg/kg every 6\u20138 hours increased in severe infections for child\r\nof 2 years or older to 50\u00a0mg/kg every 6\u20138 hours; max. 8\u00a0g daily", "Gonorrhoea, cystitis, by intramuscular injection, 1\u00a0g as a single dose", "Chronic pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis, by inhalation\r\nof nebulised solution, adult over 18 years, 75\u00a0mg 3 times daily (at least 4 hours apart) for\r\n28 days; if additional courses required, a minimum of 28 days without\r\naztreonam nebuliser solution recommended between courses", "Name[Cayston\u00ae (Gilead)  ] Powder for nebuliser solution, aztreonam\r\n(as lysine), net price 84 \u00d7 75\u00a0mg vials (with solvent and nebuliser\r\nhandset) = \u00a32566.50"], "pregnancy": "Pregnancy\u00a0no information available; manufacturer of injection\r\nadvises avoid; manufacturer of powder for nebuliser solution advises\r\navoid unless essential"}, {"indications": "Indications\u00a0Gram-negative infections including Pseudomonas aeruginosa, Haemophilus influenzae, and Neisseria\r\nmeningitidis", "name": "AZTREONAM", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.2 Cephalosporins, carbapenems, and other beta-lactams", "5.1.2.3 Other beta-lactam antibiotics"], "cautions": "Cautions\u00a0hypersensitivity to beta-lactam antibiotics; interactions: Appendix 1 (aztreonam)Specific cautions for inhaled treatment\u00a0Other\r\ninhaled drugs should be administered before aztreonam; a bronchodilator\r\nshould be administered before each dose ", "side-effects": "Side-effects\u00a0Specific side-effects for parenteral treatment\u00a0Rarely gastro-intestinal bleeding, antibiotic-associated\r\ncolitis, jaundice, hepatitis, hypotension, chest pain, dyspnoea, seizures,\r\nparaesthesia, confusion, dizziness, asthenia, headache, insomnia,\r\nbreast tenderness, blood disorders (including thrombocytopenia and\r\nneutropenia), myalgia, diplopia, tinnitus, halitosis; also reported\r\nnausea, vomiting, abdominal pain, diarrhoea, mouth ulcers,\r\ntaste disturbances, flushing, bronchospasm, rash (including toxic\r\nepidermal necrolysis and erythema multiforme)Specific side-effects for inhaled treatment\u00a0Wheezing,\r\nbronchospasm, cough; pyrexia; rash; rhinorrhoea, pharyngolaryngeal\r\npain", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3800.htm", "doses": ["By deep intramuscular injection or by intravenous injection over 3\u20135 minutes or by intravenous infusion, 1\u00a0g every 8 hours or 2\u00a0g every 12 hours; 2\u00a0g every 6\u20138 hours for severe infections\r\n(including systemic Pseudomonas aeruginosa and\r\nlung infections in cystic fibrosis); single doses over 1\u00a0g intravenous\r\nroute only", "Urinary-tract infections, 0.5\u20131\u00a0g every 8\u201312 hours", "child over 1 week, by\r\nintravenous injection or infusion, 30\u00a0mg/kg every 6\u20138 hours increased in severe infections for child\r\nof 2 years or older to 50\u00a0mg/kg every 6\u20138 hours; max. 8\u00a0g daily", "Gonorrhoea, cystitis, by intramuscular injection, 1\u00a0g as a single dose", "Chronic pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis, by inhalation\r\nof nebulised solution, adult over 18 years, 75\u00a0mg 3 times daily (at least 4 hours apart) for\r\n28 days; if additional courses required, a minimum of 28 days without\r\naztreonam nebuliser solution recommended between courses"], "pregnancy": "Pregnancy\u00a0no information available; manufacturer of injection\r\nadvises avoid; manufacturer of powder for nebuliser solution advises\r\navoid unless essential"}]